Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -3.405% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CON(C)c1nc(NCC(C)C)nc(OCC#N)n1
b.) Cn1ncc([N+](=O)[O-])c1C(=O)Nc1ccccc1C(=O)O
c.) COc1ccc(S(=O)(=O)N2CCOC2CNC(=O)C(=O)NCc2ccc3c(c2)OCO3)cc1
d.) CC(C)(C)c1cc(C(C)(C)C)cc(S(=O)(=O)CCc2ccccn2)c1
Answer: a. CON(C)c1nc(NCC(C)C)nc(OCC#N)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CON(C)c1nc(NCC(C)C)nc(OCC#N)n1
CON(C)c1nc(NCC(C)C)nc(OCC#N)n1
2-[[4-[methoxy(methyl)amino]-6-(2-methylpropylamino)-1,3,5-triazin-2-yl]oxy]acetonitrile